Best practices to alleviate FOMO in social media listening for pharma

Today's post comes from ePharma sponsor Visible.  This post is cross-posted from the Visible blog.Best practices to alleviate FOMO in social media listening for pharmaPharmaceutical companies have come a long way when it comes to social media, and most companies have acknowledged that there are rich consumer insights that can be gleaned. But a lot still suffer from a bad case of FOMO or ‘fear of missing out’ while being inundated by numerous irrelevant and spam posts. This primarily results from the fact that many people in pharma are always unsure of where to start, what to focus on, and how to analyze social media data.Here are some things to consider when setting up your social listening strategy in 2014:Key points and questions to help you focus:Recognize that patient discussion is mostly centered on the condition and brand names as opposed to company names.How do consumers refer to the disease? Do they use shortcuts, such as “P” for Psoriasis or “T1DM” for Type 1 Diabetes?Define your competitive set. Are these all focused on a single indication or disease directly competing against your product? If not, what are the conditions or uses that should be removed from the data set?Are you interested in a global view? Do the major brand players have name variations per country?Do we need discussions around clinical trial results, pipeline news, coupon posts and financial news discussion? If we want to focus on pure consumer insights, I suggest that we eliminate...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: ePharma Summit Pharma Consumer Insights Source Type: blogs